Report Overview

The global Brachytherapy market was picked at US$ 1.08 billion in 2021 and is expected to witness a CAGR of 7.95 % during the forecast period

Market Fundamentals 

Brachytherapy is a form of internal radiation therapy consist of radiation-containing seeds, ribbons, or capsules. They are inserted into or close to the tumors in the body to eradicate cancer cells and reduce tumor size. A single body component can only be treated locally using brachytherapy. Cancers of the reproductive system, breast, head and neck, and eye are among those frequently treated with it. This enables the treatment of a smaller area with a higher overall dosage of radiation while avoiding radiation exposure to some nearby organs. Brachytherapy can be applied as a preventative measure, palliative measure, or curative measure. Additionally, it can be administered alone or as an adjuvant with chemotherapy, immunotherapy, and surgery.

[8094832]

Market Dynamics

The global brachytherapy market is driven by increasing demand of using highly localized radiation treatments over the conventional one. Physicians are using radiation more frequently because of its many applications. The most recent developments in radiation therapy enable the delivery of a high dose to the target area with little harm to the healthy tissues in the immediate vicinity. As a result, there is now more demand for radiation therapy as the likelihood of localized tumor control has grown and the cure rate has improved. Thus, less time consumption coupled with acclamatory health indemnification endeavor the significant growth opportunities for the global brachytherapy market. 

However, this market is projected to be significantly constrained by the absence of highly qualified radiation specialists and availability to cutting-edge products, particularly in emerging nations. Furthermore, it is anticipated that side effects from brachytherapy treatments, such as swelling, pain, bleeding, and discomfort at the treatment site along with short-term or intermittent urine problems, may restrain market expansion.

Market Ecosystem

The global brachytherapy market has been analyzed from four perspectives: product, dosage type/techniques, application, end user, and region

Brachytherapy Market by Product 

[4635434]

Based on the distribution of the products, the brachytherapy market has been segmented into seeds, brachytherapy after loader, brachytherapy applicators, electronic brachytherapy, and others. Due to the growing use of applicators during the treatment of gynecological cancers and other cancers to reduce radiation exposure to surrounding healthy tissues and organs, the brachytherapy applicators segment is anticipated to experience significantly rapid revenue growth over the forecast period. Applicators aid in directing where the treatment should be administered, and medical imaging also helps in precisely positioning the applicators to treat tumors. There are several different applicators on the market for different treatments that are meant to offer more precise doses in cancer brachytherapy.

Brachytherapy Market by Dosage Type/ Technique

Based on dosage type or techniques used, the market for brachytherapy is divided into high dosage rate (HDR) brachytherapy, low dosage rate (LDR) brachytherapy, medium dosage rate (MDR) brachytherapy, ultra-low dosage rate brachytherapy, pulse dosage rate (PDR) brachytherapy, image guided brachytherapy and others. HDR is found to be the largest revenue share of the global brachytherapy market over the forecast period. HDR brachytherapy involves a radiation source temporarily inserting a catheter into the tumor's region. The procedure enables the brief implantation of highly radioactive material inside the body to eliminate undesirable or potentially harmful cells. Remote control is used to withdraw the radioactive material. Additionally, HDR brachytherapy is carried out as an outpatient operation, which makes it more practical and affordable. This is another aspect anticipated to support the segment's revenue growth throughout the forecast period. 

Brachytherapy Market by Application

The global market for brachytherapy is segmented into different application areas, such as gynecological cancer, prostate cancer, anal/rectal cancer, breast cancer, and esophageal cancer. The prostate cancer market is reported to dominate and account for the largest income share of the global brachytherapy market. For all patients with restricted prostate cancer development, brachytherapy is a promising treatment option, both alone and in combination with outer bar radiation therapy. The category is being driven by the promising applications of brachytherapy in the treatment of prostate cancer in 2021. Moreover, it was observed that the breast cancer brachytherapy application segment will register a significant CAGR throughout the projection period. Breast Cancer considered as the fastest growing segment in brachytherapy market because one of the main factors influencing the growth of this market is the rising incidence of breast cancer will fuel the growth of this market.

Brachytherapy Market by End User

The global market for brachytherapy is segmented into hospitals, cancer treatment facilities, speciality clinics, clinical laboratories, academic & medical centers, and others based on end user. Of these, hospitals own the major market share. Better medical facilities, enticing insurance plans, and people's preference for choosing hospitals with top-notch medical staff are some of the main causes of this. Current increase in cancer prevalence, hospitals are also receiving government funding. However, due to the rise in privacy concerns and the creation of specialized facilities with more individualized & practical alternatives for patients, cancer treatment clinics will also experience consistent growth in the brachytherapy devices market.

Brachytherapy Market by Region

The regional divisions for the global brachytherapy market have been established over North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and the Rest of the World. A large portion of the revenue of global brachytherapy market is envisioned to come from North America during the forecast period. Due to the region's rising cancer incidence, potentially generate in brachytherapy treatment, ongoing research-based practices, and accessibility to cutting-edge brachytherapy equipment the market is expanded. During the projected period, growth in the market is likely to be sustained by additional factors like high product launch rates, advantageous reimbursement circumstances, and rising investments in R&D activities.

Competitive Landscape

Some of the predominant companies operating in the brachytherapy market are Eckert & Ziegler BEBIG S.A., Elekta AB, iCAD Inc., Varian Medical Systems, Inc., Sun Nuclear Corporation, CIVCO Medical Solutions, Theragenics Corporation, Argon Medical Devices, Inc., C.R. Bard Inc., Huiheng Medical Inc., Isoray Medical Inc., Becton, Dickinson & Company, Carl Zeiss Meditec AG, Bard Medical Division, Best Medical International, Inc. among others.

Strategic Development

• In November 2022, The Radiotherapy team at Sultan Qaboos Comprehensive Cancer Care and Research Center (SQCCCRC) has successfully completed the first of Low Dose Rate (LDR) brachytherapy seed implants for prostate cancer. 
• In October 2021, Edinburg Cancer Center announced that it would be providing High Dose Rate Brachytherapy (HDR-BT) for the treatment of severe prostate cancer. 

Frequently Asked Questions About This Report